Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07288294

PRImary Care Strategies for Weight Management (PRISM) Study

Primary-Care Strategies to Enhance Weight Management (PRISM) After Discontinuation of Anti-Obesity Medications

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
214 (estimated)
Sponsor
Rush University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial pilot is to determine the feasibility of an intervention to enhance weight management in patients who have stopped taking anti-obesity/weight management medications in primary care. The main questions it aims to answer are: * Can patients be recruited into the study efficiently? * Is the program acceptable to patients? * Can the study be conducted efficiently? The new program will be compared to usual care. Participants will be asked to 1) complete short surveys about their medication use while taking the weight management medication, 2) complete online visits using study-provided scales, and 3) complete video visits with study staff monthly and online check-ins weekly, if assigned to the active treatment group.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPRISM ProgramThis is a novel, remotely delivered, self-tailored intervention for post-anti-obesity medication discontinuation weight management. The program incorporates standard-of-care behavioral intervention strategies for weight control to improve routine self-weighing, dietary self-monitoring, and increasing physical activity. The program includes an enhanced focus on strategies to reduce food cue reactivity. The program includes six monthly one-on-one sessions between study staff and participants, asynchronous online check-ins weekly for 12 weeks, and bi-weekly for 12 weeks.

Timeline

Start date
2026-03-01
Primary completion
2028-04-01
Completion
2028-04-01
First posted
2025-12-17
Last updated
2025-12-17

Source: ClinicalTrials.gov record NCT07288294. Inclusion in this directory is not an endorsement.